{"name":"Chang Yingjun","slug":"chang-yingjun","ticker":"","exchange":"","domain":"","description":"Chang Yingjun is a biotechnology company focused on developing innovative CAR-T cell therapies for cancer treatment. The company's lead product, CD19-BCMA dual nanobody based CAR-T Cells, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-08-07","type":"pipeline","source":"South China Morning Post","summary":"Sunshine Lake Pharma falls in Hong Kong stock market debut - South China Morning Post","headline":"Sunshine Lake Pharma falls in Hong Kong stock market debut","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}